These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2649696)

  • 21. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
    Lynch M; Yanes L; Todd K
    Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.
    Russo CL; Glader BE; Israel RJ; Galasso F
    Lancet; 1990 Sep; 336(8717):751-2. PubMed ID: 1975922
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expectations in the clinical application of human-recombinant cytokines. 4) Interleukin-3 and colony-stimulation factors].
    Takaku F
    Nihon Rinsho; 1988 May; 46(5):1105-11. PubMed ID: 2457722
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
    Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
    [No Abstract]   [Full Text] [Related]  

  • 25. [Agranulocytosis treatment with rhGM-CSF].
    Rosien U; Benker G; Brittinger G; Reinwein D
    Dtsch Med Wochenschr; 1989 Nov; 114(47):1861. PubMed ID: 2684585
    [No Abstract]   [Full Text] [Related]  

  • 26. The impact of colony stimulating factors on cancer chemotherapy.
    Morstyn G
    Br J Haematol; 1990 Jul; 75(3):303-7. PubMed ID: 1696832
    [No Abstract]   [Full Text] [Related]  

  • 27. Colony-stimulating factor and drug-induced agranulocytosis.
    Delannoy A; Géhenot M
    Ann Intern Med; 1989 Jun; 110(11):942-3. PubMed ID: 2655524
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia.
    Krieger G; Kneba M; Vehmeyer K; Nagel GA; Welte K
    Eur J Haematol; 1990 Mar; 44(3):205-6. PubMed ID: 2184048
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful use of granulocyte-macrophage colony-stimulating factor in patients with acute lymphocytic leukemia.
    Smith T; Grossberg H
    Am J Med; 1990 Sep; 89(3):384-6. PubMed ID: 2203265
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 31. Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugs.
    Krumwieh D; Schulz G; Seiler FR
    Behring Inst Mitt; 1988 Apr; (82):265-81. PubMed ID: 2457362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of tumor necrosis factor alpha in patients treated with granulocyte-macrophage colony-stimulating factor.
    Stehle B; Weiss C; Ho AD; Hunstein W
    Blood; 1990 May; 75(9):1895-6. PubMed ID: 1970488
    [No Abstract]   [Full Text] [Related]  

  • 33. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM-CSF may hasten patient recovery while reducing costs.
    Oncology (Williston Park); 1989 Jul; 3(7):56, 59. PubMed ID: 2701812
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-infectious responses in Leishmania major-infected BALB/c mice injected with recombinant granulocyte-macrophage colony-stimulating factor.
    Solbach W; Greil J; Röllinghoff M
    Ann Inst Pasteur Immunol; 1987; 138(5):759-62. PubMed ID: 3326625
    [No Abstract]   [Full Text] [Related]  

  • 36. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
    Farmer KL; Kurzrock R; Gutterman JU; Duvic M
    Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
    [No Abstract]   [Full Text] [Related]  

  • 37. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
    Yamashita J; Kawamura T; Shoin K
    No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant human GM-CSF in myelosuppression of chemotherapy (continued).
    Bar MH; Aronson FR
    N Engl J Med; 1989 Apr; 320(14):939-40. PubMed ID: 2648149
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinant GM-CSF in myelosuppression of chemotherapy.
    N Engl J Med; 1989 Jan; 320(4):253-4. PubMed ID: 2643049
    [No Abstract]   [Full Text] [Related]  

  • 40. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies.
    Lazarus HM
    Prog Clin Biol Res; 1990; 352():531-8. PubMed ID: 1698303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.